(4483) Stock Price

JMDC is part of a corporate group with Omron Corporation as its parent company and operates alongside 38 subsidiaries. JMDC's business is divided into two segments: "Health Big Data" and "Telemedicine."

The Health Big Data segment operates three main business lines: industry-focused business, business for insurers and consumers, and business for healthcare providers. In the industry-focused business, JMDC provides anonymized epidemiological data to pharmaceutical companies and insurance companies.

In the business for insurers and consumers, JMDC supports health promotion programs for health insurance associations and provides Personal Health Record (PHR) services to members. Through the health information platform "Pep Up," JMDC displays health checkup results and medical expense notifications to support health management.

In the business for healthcare providers, JMDC operates a pharmaceutical database business and provides consulting services to medical institutions. The pharmaceutical database business develops databases based on pharmaceutical information and provides them to healthcare IT system companies.

The Telemedicine segment provides remote diagnostic services for medical imaging through Doctor Net Inc. By accepting remote diagnostic requests for CT and MRI scans and delivering diagnostic reports from contracted radiologists, JMDC helps address the shortage of specialized radiologists.

JMDC operates under the corporate mission of "healthy and prosperous lives for all." The company addresses social challenges including rising healthcare costs, regional disparities, and increasing lifestyle diseases by leveraging data and ICT solutions. Looking ahead, JMDC aims to expand its expertise in solving Japan's super-aging society challenges to other Asian countries.

The company's medium to long-term management strategy focuses on maximizing transaction value from data utilization services. JMDC plans to expand service offerings and increase transaction value per customer by enhancing data value-added services and diversifying data types for pharmaceutical companies, insurance providers, and academic institutions. Through its health information platform "Pep Up," the company is advancing causal analysis in healthcare and wellness by leveraging data synergies.

JMDC is committed to advancing and improving healthcare efficiency through data-driven value creation. In the telemedicine segment, the company provides diagnostic support powered by AI technology to help reduce healthcare costs. Additionally, through a partnership with Omron Corporation, JMDC is developing preventive solutions and expanding internationally.

JMDC aims to establish its PHR service "Pep Up" as a nationwide platform to enable personalized medicine and outcome-based healthcare. By collaborating with health insurance associations and corporations, the company develops intervention strategies using data and measures their effectiveness, contributing to healthcare cost reduction. This approach supports revenue growth through national healthcare cost containment.